Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3109)
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
5,044
Price
$50.02
Total Value
$252.29K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
3,795
Price
$49.32
Total Value
$187.17K
Shares Held After
5,044
% of Holdings
42.9%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
6,161
Price
$48.20
Total Value
$296.98K
Shares Held After
8,839
% of Holdings
41.1%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
1,200
Price
$79.94
Total Value
$95.93K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
600
Price
$79.24
Total Value
$47.55K
Shares Held After
1,200
% of Holdings
33.3%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
700
Price
$77.71
Total Value
$54.40K
Shares Held After
1,800
% of Holdings
28.0%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
1,596
Price
$18.95
Total Value
$30.25K
Shares Held After
339,392
% of Holdings
0.5%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
6,905
Price
$18.78
Total Value
$129.70K
Shares Held After
339,392
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$532.90
Total Value
$21.32K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$531.90
Total Value
$127.66K
Shares Held After
40,553
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,431
Price
$531.20
Total Value
$760.15K
Shares Held After
40,793
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,608
Price
$530.20
Total Value
$852.56K
Shares Held After
42,224
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,950
Price
$529.32
Total Value
$1.03M
Shares Held After
43,832
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,241
Price
$528.31
Total Value
$655.63K
Shares Held After
45,782
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,515
Price
$527.30
Total Value
$798.86K
Shares Held After
47,023
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
876
Price
$526.27
Total Value
$461.01K
Shares Held After
48,538
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
599
Price
$525.08
Total Value
$314.52K
Shares Held After
49,414
% of Holdings
1.2%
INSMED Inc (INSM)
Lewis William — Director
Shares
4,533
Price
$144.11
Total Value
$653.25K
Shares Held After
301,185
% of Holdings
1.5%
INSMED Inc (INSM)
Lewis William — Director
Shares
4,537
Price
$143.42
Total Value
$650.70K
Shares Held After
305,718
% of Holdings
1.5%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,629
Price
$142.17
Total Value
$231.59K
Shares Held After
310,255
% of Holdings
0.5%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
39,000
Price
$2.50
Total Value
$97.50K
Shares Held After
0
% of Holdings
100.0%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
1,163
Price
$97.44
Total Value
$113.32K
Shares Held After
58,518
% of Holdings
1.9%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
11,964
Price
$67.00
Total Value
$801.59K
Shares Held After
33,421
% of Holdings
26.4%
Tarsus Pharmaceuticals, Inc. (TARS)
Farrow Jeffrey S — Chief Financial Officer and Chief Strategy Officer
Shares
2,186
Price
$67.00
Total Value
$146.46K
Shares Held After
43,316
% of Holdings
4.8%
Tarsus Pharmaceuticals, Inc. (TARS)
Neervannan Seshadri — Chief Operating Officer
Shares
4,589
Price
$67.00
Total Value
$307.46K
Shares Held After
85,780
% of Holdings
5.1%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
390
Price
$67.00
Total Value
$26.13K
Shares Held After
23,308
% of Holdings
1.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
4,174
Price
$67.00
Total Value
$279.66K
Shares Held After
35,028
% of Holdings
10.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Mottiwala Aziz — Chief Commercial Officer
Shares
4,440
Price
$67.00
Total Value
$297.48K
Shares Held After
61,480
% of Holdings
6.7%
Tarsus Pharmaceuticals, Inc. (TARS)
Wahl Bryan — General Counsel
Shares
4,231
Price
$67.00
Total Value
$283.48K
Shares Held After
63,959
% of Holdings
6.2%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
1,461
Price
$29.99
Total Value
$43.82K
Shares Held After
40,702
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
80
Price
$533.41
Total Value
$42.67K
Shares Held After
45,172
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
650
Price
$532.50
Total Value
$346.12K
Shares Held After
45,252
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
794
Price
$531.62
Total Value
$422.11K
Shares Held After
45,902
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,776
Price
$530.63
Total Value
$942.41K
Shares Held After
46,696
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,808
Price
$529.82
Total Value
$1.49M
Shares Held After
48,472
% of Holdings
5.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,439
Price
$528.41
Total Value
$760.38K
Shares Held After
51,280
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
753
Price
$527.47
Total Value
$397.18K
Shares Held After
52,719
% of Holdings
1.4%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
6,499
Price
$18.84
Total Value
$122.41K
Shares Held After
339,392
% of Holdings
1.9%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
2,877
Price
$24.97
Total Value
$71.84K
Shares Held After
147,053
% of Holdings
1.9%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
304
Price
$119.08
Total Value
$36.20K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,730
Price
$118.37
Total Value
$204.78K
Shares Held After
304
% of Holdings
85.1%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
2,268
Price
$117.56
Total Value
$266.63K
Shares Held After
2,034
% of Holdings
52.7%
ARVINAS, INC. (ARVN)
Berkowitz Noah — Chief Medical Officer
Shares
6,435
Price
$11.10
Total Value
$71.43K
Shares Held After
202,503
% of Holdings
3.1%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
11,667
Price
$68.71
Total Value
$801.64K
Shares Held After
45,385
% of Holdings
20.4%
Tarsus Pharmaceuticals, Inc. (TARS)
Farrow Jeffrey S — Chief Financial Officer and Chief Strategy Officer
Shares
2,133
Price
$68.71
Total Value
$146.56K
Shares Held After
45,502
% of Holdings
4.5%
Tarsus Pharmaceuticals, Inc. (TARS)
Neervannan Seshadri — Chief Operating Officer
Shares
3,610
Price
$68.71
Total Value
$248.04K
Shares Held After
90,369
% of Holdings
3.8%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
379
Price
$68.71
Total Value
$26.04K
Shares Held After
23,698
% of Holdings
1.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
4,071
Price
$68.71
Total Value
$279.72K
Shares Held After
39,202
% of Holdings
9.4%
Tarsus Pharmaceuticals, Inc. (TARS)
Mottiwala Aziz — Chief Commercial Officer
Shares
4,330
Price
$68.71
Total Value
$297.51K
Shares Held After
65,920
% of Holdings
6.2%
Tarsus Pharmaceuticals, Inc. (TARS)
Wahl Bryan — General Counsel
Shares
4,125
Price
$68.71
Total Value
$283.43K
Shares Held After
68,190
% of Holdings
5.7%
Showing 1–50 of 3109 transactions (page 1 of 63)